United States Bevacizumab Biosimilar Market Report 2016

United States Bevacizumab Biosimilar Market Report 2016

1 Bevacizumab Biosimilar Overview

1.1 Product Overview and Scope of Bevacizumab Biosimilar

1.2 Classification of Bevacizumab Biosimilar

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Bevacizumab Biosimilar

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Bevacizumab Biosimilar (2011-2021)

1.4.1 USA Bevacizumab Biosimilar Sales and Growth Rate (2011-2021)

1.4.2 USA Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

2 USA Bevacizumab Biosimilar Competition by Manufacturers

2.1 USA Bevacizumab Biosimilar Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Bevacizumab Biosimilar Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Bevacizumab Biosimilar Average Price by Manufactures (2015 and 2016)

2.4 Bevacizumab Biosimilar Market Competitive Situation and Trends

2.4.1 Bevacizumab Biosimilar Market Concentration Rate

2.4.2 Bevacizumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Bevacizumab Biosimilar Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Bevacizumab Biosimilar Sales and Market Share by Type (2011-2016)

3.2 USA Bevacizumab Biosimilar Revenue and Market Share by Type (2011-2016)

3.3 USA Bevacizumab Biosimilar Price by Type (2011-2016)

3.4 USA Bevacizumab Biosimilar Sales Growth Rate by Type (2011-2016)

4 USA Bevacizumab Biosimilar Sales (Volume) by Application (2011-2016)

4.1 USA Bevacizumab Biosimilar Sales and Market Share by Application (2011-2016)

4.2 USA Bevacizumab Biosimilar Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Bevacizumab Biosimilar Manufacturers Profiles/Analysis

5.1 Pfizer

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Allergan

5.2.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Allergan Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Alnylam Pharmaceuticals

5.3.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Alnylam Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Amgen

5.4.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Amgen Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Angstrom Pharmaceuticals

5.5.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Angstrom Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Acceleron Pharma

5.6.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Acceleron Pharma Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Biocon

5.7.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Biocon Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bionomics

5.8.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bionomics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 CASI Pharmaceuticals

5.9.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 CASI Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Celgene Corporation

5.10.2 Bevacizumab Biosimilar Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Celgene Corporation Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Enzon Pharmaceuticals

5.12 Five Prime Therapeutics

5.13 Fujifilm Kyowa Kirin Biologics

5.14 Genentech

5.15 Genexine

5.16 Hetero Drugs

5.17 ImClone Systems

5.18 Intas Pharmaceuticals

5.19 Kyowa Hakko Kirin

5.20 Levolta Pharmaceuticals

5.21 Mabtech

5.22 Marsala Biotech

5.23 Neumedicines

5.24 Novartis

5.25 Oncobiologics

5.26 Onyx Pharmaceuticals

6 Bevacizumab Biosimilar Manufacturing Cost Analysis

6.1 Bevacizumab Biosimilar Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Bevacizumab Biosimilar Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Bevacizumab Biosimilar Market Forecast (2016-2021)

10.1 USA Bevacizumab Biosimilar Sales, Revenue Forecast (2016-2021)

10.2 USA Bevacizumab Biosimilar Sales Forecast by Type (2016-2021)

10.3 USA Bevacizumab Biosimilar Sales Forecast by Application (2016-2021)

10.4 Bevacizumab Biosimilar Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Bevacizumab Biosimilar

Table Classification of Bevacizumab Biosimilar

Figure USA Sales Market Share of Bevacizumab Biosimilar by Type in 2015

Table Application of Bevacizumab Biosimilar

Figure USA Sales Market Share of Bevacizumab Biosimilar by Application in 2015

Figure USA Bevacizumab Biosimilar Sales and Growth Rate (2011-2021)

Figure USA Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

Table USA Bevacizumab Biosimilar Sales of Key Manufacturers (2015 and 2016)

Table USA Bevacizumab Biosimilar Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Bevacizumab Biosimilar Sales Share by Manufacturers

Figure 2016 Bevacizumab Biosimilar Sales Share by Manufacturers

Table USA Bevacizumab Biosimilar Revenue by Manufacturers (2015 and 2016)

Table USA Bevacizumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Bevacizumab Biosimilar Revenue Share by Manufacturers

Table 2016 USA Bevacizumab Biosimilar Revenue Share by Manufacturers

Table USA Market Bevacizumab Biosimilar Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Bevacizumab Biosimilar Average Price of Key Manufacturers in 2015

Figure Bevacizumab Biosimilar Market Share of Top 3 Manufacturers

Figure Bevacizumab Biosimilar Market Share of Top 5 Manufacturers

Table USA Bevacizumab Biosimilar Sales by Type (2011-2016)

Table USA Bevacizumab Biosimilar Sales Share by Type (2011-2016)

Figure USA Bevacizumab Biosimilar Sales Market Share by Type in 2015

Table USA Bevacizumab Biosimilar Revenue and Market Share by Type (2011-2016)

Table USA Bevacizumab Biosimilar Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Bevacizumab Biosimilar by Type (2011-2016)

Table USA Bevacizumab Biosimilar Price by Type (2011-2016)

Figure USA Bevacizumab Biosimilar Sales Growth Rate by Type (2011-2016)

Table USA Bevacizumab Biosimilar Sales by Application (2011-2016)

Table USA Bevacizumab Biosimilar Sales Market Share by Application (2011-2016)

Figure USA Bevacizumab Biosimilar Sales Market Share by Application in 2015

Table USA Bevacizumab Biosimilar Sales Growth Rate by Application (2011-2016)

Figure USA Bevacizumab Biosimilar Sales Growth Rate by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Angstrom Pharmaceuticals Basic Information List

Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Acceleron Pharma Basic Information List

Table Acceleron Pharma Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Acceleron Pharma Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biocon Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Bionomics Basic Information List

Table Bionomics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bionomics Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table CASI Pharmaceuticals Basic Information List

Table CASI Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table CASI Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Celgene Corporation Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Enzon Pharmaceuticals Basic Information List

Table Enzon Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Enzon Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Five Prime Therapeutics Basic Information List

Table Five Prime Therapeutics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Five Prime Therapeutics Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Basic Information List

Table Fujifilm Kyowa Kirin Biologics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Genexine Basic Information List

Table Genexine Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genexine Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Hetero Drugs Basic Information List

Table Hetero Drugs Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hetero Drugs Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table ImClone Systems Basic Information List

Table ImClone Systems Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table ImClone Systems Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Intas Pharmaceuticals Basic Information List

Table Intas Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Intas Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Kyowa Hakko Kirin Basic Information List

Table Kyowa Hakko Kirin Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kyowa Hakko Kirin Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Levolta Pharmaceuticals Basic Information List

Table Levolta Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Levolta Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Mabtech Basic Information List

Table Mabtech Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mabtech Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Marsala Biotech Basic Information List

Table Marsala Biotech Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Marsala Biotech Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Neumedicines Basic Information List

Table Neumedicines Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neumedicines Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Oncobiologics Basic Information List

Table Oncobiologics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Oncobiologics Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Table Onyx Pharmaceuticals Bevacizumab Biosimilar Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Bevacizumab Biosimilar

Figure Manufacturing Process Analysis of Bevacizumab Biosimilar

Figure Bevacizumab Biosimilar Industrial Chain Analysis

Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015

Table Major Buyers of Bevacizumab Biosimilar

Table Distributors/Traders List

Figure USA Bevacizumab Biosimilar Production and Growth Rate Forecast (2016-2021)

Figure USA Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)

Table USA Bevacizumab Biosimilar Production Forecast by Type (2016-2021)

Table USA Bevacizumab Biosimilar Consumption Forecast by Application (2016-2021)